Results 11 to 20 of about 430 (135)

Management of Mycosis Fungoides With Chlormethine Hydrochloride Gel in Combination With Systemic Therapies: A Case Series [PDF]

open access: yesCase Reports in Dermatological Medicine
Background Mycosis fungoides (MF) is a subtype of T‐cell lymphoma that is characterised by the infiltration of malignant T cells into the skin. Treatment approaches usually include skin‐directed therapies for early‐stage disease and, additionally, systemic therapies for advanced stages.
Gabor Dobos   +6 more
doaj   +6 more sources

Adsorption of Chlormethine Anti-Cancer Drug on Pure and Aluminum-Doped Boron Nitride Nanocarriers: A Comparative DFT Study [PDF]

open access: yesPharmaceuticals, 2022
The efficacy of pure and aluminum (Al)-doped boron nitride nanocarriers (B12N12 and AlB11N12) in adsorbing Chlormethine (CM), an anti-cancer drug, was comparatively dissected by means of the density functional theory method.
Mahmoud A. A. Ibrahim   +8 more
doaj   +5 more sources

Multidisciplinary and personalized approach to the management of mycosis fungoides with chlormethine gel: a collection of clinical experiences [PDF]

open access: yesDrugs in Context
Topical chlormethine (CL) gel formulation was approved by the EMA in 2017 for the treatment of adult patients with mycosis fungoides (MF). To expand the knowledge on the management of patients with MF, this paper provides an overview of clinical practice
Silvia Alberti Violetti   +11 more
doaj   +4 more sources

Clinical outcomes of chlormethine gel in mycosis fungoides affecting "sensitive" areas: A retrospective case series. [PDF]

open access: yesJ Dtsch Dermatol Ges
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 23, Issue 11, Page 1447-1450, November 2025.
Tavoletti G   +6 more
europepmc   +5 more sources

Chlormethine Gel Versus Chlormethine Ointment for Treatment of Patients with Mycosis Fungoides: A Post-Hoc Analysis of Clinical Trial Data. [PDF]

open access: yesAm J Clin Dermatol, 2022
Chlormethine gel was approved for treatment of mycosis fungoides, the most common cutaneous T-cell lymphoma, on the basis of results from study 201 and study 202. A post-hoc analysis of study 201 found interesting trends regarding improved efficacy of chlormethine gel vs ointment and noted a potential association between dermatitis and clinical ...
Querfeld C   +6 more
europepmc   +5 more sources

Topical Chlormethine Gel in the Treatment of Lymphomatoid Papulosis: A Case Report and Literature Review. [PDF]

open access: yesJ Clin Med
Background: Lymphomatoid papulosis (LyP) is a primary cutaneous CD30-positive T-cell lymphoproliferative disorder presenting with self-healing erythematous papulonodular lesions that may ulcerate and scar. Treatment varies by lesion extent, location, and severity.
Teoli M   +5 more
europepmc   +5 more sources

Successful treatment of lymphomatoid papulosis with chlormethine gel

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft
No abstract available.
Tassilo Dege   +4 more
core   +5 more sources

Mechanism of action of chlormethine gel in mycosis fungoides [PDF]

open access: yesJournal of the European Academy of Dermatology and Venereology, 2023
AbstractMycosis fungoides (MF), the most common type of cutaneous T‐cell lymphoma, is characterized by proliferation of malignant skin‐tropic T cells. Progression from early‐stage disease (skin patches and/or plaques) to more advanced stages (cutaneous tumours, erythroderma or extracutaneous involvement) occurs slowly and can be discontinuous ...
E. Guenova   +3 more
core   +4 more sources

Increased Chlormethine-Induced DNA Double-Stranded Breaks in Malignant T Cells from Mycosis Fungoides Skin Lesions

open access: yesJID Innovations, 2022
Mycosis fungoides (MF) is a type of cutaneous T-cell lymphoma. Chlormethine (CL) is recommended as first-line therapy for MF, with a major purpose to kill tumor cells through DNA alkylation.
Yun-Tsan Chang   +5 more
doaj   +2 more sources

Chlormethine Hydrochloride is Not Inferior to Tacrolimus in Treating Steroid-Resistant Nephrotic Syndrome [PDF]

open access: yesKidney & Blood Pressure Research, 2018
Background/Aims: The present study aimed to explore the equivalence of CHL and tacrolimus (TAC), despite reports regarding the efficacy and safety of TAC in treating SRNS patients.
Yuan Yang   +14 more
doaj   +3 more sources

Home - About - Disclaimer - Privacy